Of note is that the transgenic suppression of IL-17A in sPLA2-IIATGN mice did not impact arthritis severity in this model (Figure 5D), and intestinal permeability did not appear modulated in sPLA2-IIATGN or arthritic mice (Figure 5E). This evidence concerns the gene IL17A and arthritic joint disease.